Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Surgery Partners ( (SGRY) ).
On December 16, 2025, Surgery Center Holdings, Inc., a subsidiary of Surgery Partners, Inc., issued an additional $425 million in 7.250% Senior Notes due 2032. This issuance is part of a single series with $800 million of existing notes issued in April 2024, and is expected to enhance the company’s financial flexibility and market positioning.
The most recent analyst rating on (SGRY) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on Surgery Partners stock, see the SGRY Stock Forecast page.
Spark’s Take on SGRY Stock
According to Spark, TipRanks’ AI Analyst, SGRY is a Neutral.
The overall stock score reflects strong revenue growth and operational efficiencies but is weighed down by persistent profitability challenges and weak technical indicators. The valuation is poor due to negative earnings, and while the earnings call and corporate events provide some positive outlook, they are not enough to offset the current financial and market challenges.
To see Spark’s full report on SGRY stock, click here.
More about Surgery Partners
Surgery Partners, Inc. operates in the healthcare industry, primarily focusing on providing surgical services through its network of surgery centers. The company is involved in the management and operation of surgical facilities and related services, catering to a wide range of medical specialties.
Average Trading Volume: 1,804,162
Technical Sentiment Signal: Sell
Current Market Cap: $2.02B
See more insights into SGRY stock on TipRanks’ Stock Analysis page.